Written question asked by Lord Mendelsohn (Labour) on Monday, 20 February 2023, in the House of Lords. It was due for an answer on Monday, 6 March 2023. It was answered by Lord Markham (Conservative) on Thursday, 2 March 2023 on behalf of the Department of Health and Social Care.
Coronavirus: Immunosuppression
- Question
-
To ask His Majesty's Government, further to the Written Answer by Lord Markham on 2 February (HL4910), whether the National Institute for Health and Care Research rapid study on those who remain vulnerable to poor outcomes from COVID-19 despite vaccination has been published; and if so, where that study can be accessed.
- Answer
-
The Department, through the National Institute for Health and Care Research, funded an extension of the QCovid 4 - Predicting risk of death or hospitalisation from COVID-19 in adults testing positive for SARS-CoV-2 infection during the Omicron wave in England study. This has now been “pre-printed”, but not peer reviewed or published. A copy of the document is attached.
Secondary information
- Type
- Written question
- Reference
- HL5696
- Session
- 2022-23
- Attachment
- QCovid 4 study
- Related items
- Subjects
- Research Coronavirus Immunosuppression
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-03-02 14:42:39 +0000
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL5696
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL5696
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/lords/2022-23/HL5696